Clinical Trials Directory

Trials / Completed

CompletedNCT03517358

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

Virological Suppression in HIV Positive Patients Involved in a Novel, Standardized Adherence Protocol

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.

Conditions

Interventions

TypeNameDescription
OTHERService of careSubjects will be receiving care from case management or clinical pharmacy.

Timeline

Start date
2018-01-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2018-05-07
Last updated
2020-07-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03517358. Inclusion in this directory is not an endorsement.

Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol (NCT03517358) · Clinical Trials Directory